Complex Dosing, Polypharmacy Common With Interstitial Lung Disease
Patients receiving systemic corticosteroids are at high risk for drug - disease interactions (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 14, 2019 Category: Respiratory Medicine Tags: Pharmacy, Pulmonology, Journal, Source Type: news

Antenatal Corticosteroid Tx Tied to Reduction in Birth Size
WEDNESDAY, Feb. 27, 2019 -- Antenatal corticosteroid therapy (ACT) is associated with reductions in birth size for infants, according to a study published online Feb. 26 in PLOS Medicine. Alina Rodriguez, Ph.D., from Imperial College London, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 27, 2019 Category: Pharmaceuticals Source Type: news

prednisone (Prednisone Intensol, Rayos) Corticosteroid
Title: prednisone (Prednisone Intensol, Rayos) CorticosteroidCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/27/2019 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - February 27, 2019 Category: Rheumatology Source Type: news

Antenatal Steroids Tied to Lower Infant Birth Weight
(MedPage Today) -- Antenatal corticosteroids therapy is " not a one-size-fits-all approach, " researcher says (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - February 26, 2019 Category: Rheumatology Source Type: news

Corticosteroid Response Phenotypes Identified for Severe Asthma
(MedPage Today) -- Patients with late-onset asthma, low lung function most responsive (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 22, 2019 Category: Allergy & Immunology Source Type: news

New method identifies which asthma patients respond to systemic corticosteroids
(Carnegie Mellon University) Physicians will be able to predict which of their patients with severe asthma are likely to benefit from treatment with systemic corticosteroids -- and which might only suffer their side effects -- with help from a dozen clinical variables researchers have identified using machine learning techniques, say researchers at Carnegie Mellon University and the University of Pittsburgh School of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2019 Category: International Medicine & Public Health Source Type: news

Opioid Use Following IBD Flares Treated With Corticosteroids Opioid Use Following IBD Flares Treated With Corticosteroids
What percentage of patients develop new persistent opioid use following a steroid-treated IBD flare?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 31, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Association of Antibiotic Treatment With Outcomes in Patients Hospitalized for an Asthma Exacerbation Treated With Systemic Corticosteroids
This research article found patients on antibiotics had a longer hospital stay, similar rate of treatment failure, higher hospital cost and higher risk of antibiotic-related diarrhoea, vs patients not treated with antibiotics. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 30, 2019 Category: Consumer Health News Source Type: news

New guideline recommendations for the treatment of mild-to-moderate ulcerative colitis
(American Gastroenterological Association) Most patients with ulcerative colitis (UC) have mild-to-moderate disease characterized by periods of activity or remission, but practice variations exist in disease management. A new clinical guideline from the American Gastroenterological Association (AGA) published in Gastroenterology, the official journal of AGA, addresses the medical management of these patients, focusing on use of both oral and topical 5-aminosalicylates (5-ASA) medications, rectal corticosteroids and oral budesonide, to promote high-quality care for UC patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 10, 2019 Category: International Medicine & Public Health Source Type: news

Association of Corticosteroid Treatment With Outcomes in Adult Patients With Sepsis: A Systematic Review and Meta-analysis
This review of 37 RCTs (n=9,564) found that corticosteroid use was associated with reduced 28 day mortality (RR 0.90, 95% CI 0.82-0.88) vs placebo or standard supportive care. ICU mortality was also reduced (0.85, 0.77-0.94). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 9, 2019 Category: Consumer Health News Source Type: news

Long-acting inhaler combo best for curbing COPD flare-ups
Long-acting beta2-agonists plus long acting muscarinic antagonist most effective, finds Cochrane Review Related items fromOnMedica Antibiotics should be restricted for COPD, says NICE Good evidence for sublingual immunotherapy Adjuvanted trivalent flu vaccine best option for over-65s Inhaled corticosteroids linked to higher infection risk Antibiotic scrip rates lower in CAM-trained practices (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 9, 2019 Category: UK Health Source Type: news

Reducing Corticosteroid-Related Adverse Events in Asthma Reducing Corticosteroid-Related Adverse Events in Asthma
The chronic use of corticosteroids is frequently associated with adverse events in asthmatics. What strategies may help reduce these events?Current Opinion in Allergy and Clinical Immunology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 4, 2019 Category: Consumer Health News Tags: Allergy & Clinical Immunology Journal Article Source Type: news

Corticosteroid Treatment Improves Outcome in Adults With Sepsis Corticosteroid Treatment Improves Outcome in Adults With Sepsis
In adults with sepsis, treatment with corticosteroids significantly improves outcomes, according to a large analysis of published studies.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 26, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Amgen Submits Supplemental Biologics License Application For Nplate ® (romiplostim)
Application Seeks to Include Adult Patients who Have had Immune Thrombocytopenia for 12 Months or Less THOUSAND OAKS, Calif., Dec. 19, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the submission of a Supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Nplate® (romiplostim) to include the treatment of adult patients with immune thrombocytopenia (ITP) who have had ITP for 12 months or less and an insufficient response to corticosteroids, immunoglobulins or splenectomy. "Patients living with ITP need more flexibility in their treatment options, and we...
Source: Amgen News Release - December 19, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

FDA Approves Nplate ® (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia
Application Granted Priority Review Designation Approval Based on Results That Demonstrated Nplate Successfully Increased and Sustained Platelet Counts in Children Affected by Rare Blood Disorder THOUSAND OAKS, Calif., Dec. 14, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Nplate® (romiplostim) for the treatment of pediatric patients one year of age and older with immune thrombocytopenia (ITP) for at least six months who have had an insufficient response to corticosteroids, immunoglob...
Source: Amgen News Release - December 14, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Featured Review: Chronic obstructive pulmonary disease and long-acting inhalers
Conclusion  The LABA/LAMA combination is likely the best treatment in preventing COPD flare-ups. LAMA-containing inhalers appear to have an advantage over those without LAMA for preventing flare-ups.Combination inhalers (LABA/LAMA and LABA/ICS), appear more effective for controlling symptoms than single-agent therapies (LAMA and LABA). Inhaled steroids carry an increased risk of pneumonia.Yuji Oba, lead author of this Cochrane review said, “ There are a range of different treatments for COPD, and this review provides a comprehensive assessment of how effective they are at preventing flare ups of COPD, managing s...
Source: Cochrane News and Events - December 6, 2018 Category: Information Technology Authors: Katie Abbotts Source Type: news

Alimera Sciences wins Health Canada nod for diabetic macular edema implant
Alimera Sciences (NSDQ:ALIM) said last month that it won approval in Canada for its intravitreal implant designed to treat diabetic macular edema. The Iluvien device is a sustained release implant that delivers fluocinolone acetonide and is indicated to treat diabetic macular edema in people who have been previously given corticosteroids and did not have a clinically significant rise in intraocular pressure. Get the full story at our sister site, Drug Delivery Business News. The post Alimera Sciences wins Health Canada nod for diabetic macular edema implant appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - December 5, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Optical/Ophthalmic Pharmaceuticals Regulatory/Compliance Wall Street Beat Alimera Sciences Knight Therapeutics Source Type: news

How Can Nanotechnologies Aid Implantable Drug-Delivery Systems?
Implantable technologies have come a long way over the years, and advancements in micro and nanotechnologies have helped device developers continue to push the envelope even further. Within the realm of drug delivery, advances in nanotechnologies have consistently improved patient outcomes by enabling sustained drug delivery to help treat chronic conditions. These scalable technologies have even offered localized drug delivery that can further improve bioavailability. While many of these technologies offer a variety of opportunities, we’re still eagerly awaiting to see the impact of these advancements onc...
Source: MDDI - November 29, 2018 Category: Medical Devices Authors: Kristopher Sturgis Tags: BIOMEDevice San Jose Implants Source Type: news

Corticosteroids are linked to an increased risk of irregular heart beat
(Natural News) Taking corticosteroids, such as prednisone, can increase your risk of suffering from irregular heartbeats, making you more likely to suffer from a heart condition, according to a study published in the Archives of Internal Medicine. Corticosteroids are naturally occurring hormones with a wide array of functions, including managing your stress response and regulating... (Source: NaturalNews.com)
Source: NaturalNews.com - November 16, 2018 Category: Consumer Health News Source Type: news

Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation
This review states that the combination of thiamine, ascorbic acid, and hydrocortisone has recently emerged as a potential adjunctive therapy to antibiotics, infectious source control, and supportive care for patients with sepsis and septic shock. In the present manuscript, the authors provide a comprehensive review of the pathophysiologic basis and supporting research for each element of the thiamine, ascorbic acid, and hydrocortisone drug combination in sepsis. In addition, they describe potential areas of synergy between these therapies and discuss the strengths/weaknesses of the two studies to date which have evaluated...
Source: Current Awareness Service for Health (CASH) - November 16, 2018 Category: Consumer Health News Source Type: news

Transcriptomic Signatures in Sepsis and a Differential Response to Steroids: From the VANISH Randomized Trial
This research article states that there remains uncertainty about the role of corticosteroids in sepsis with clear beneficial effects on shock duration but conflicting survival effects. Two transcriptomic sepsis response signatures (SRS) have been identified. SRS1 is relatively immunosuppressed whilst SRS2 is relatively immunocompetent. The Transcriptomic profile at onset of septic shock was associated with response to corticosteroids. The study concludes that those with the immuno-competent SRS2 endotype had significantly higher mortality when given corticosteroids compared to placebo. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 16, 2018 Category: Consumer Health News Source Type: news

Muscarinic Antagonists Plus Inhaled Steroids for Asthma Muscarinic Antagonists Plus Inhaled Steroids for Asthma
This POEM addresses the clinical question of whether long-acting muscarinic antagonists are a useful adjunct to inhaled corticosteroids in patients with persistent asthma.American Family Physician (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 16, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

What Causes Post-Inflammatory Hypopigmentation?
Discussion Hypopigmentation can be worrisome for many families because of cosmesis and the worry that “something is wrong.” The normal natural changes in skin-tone over the year due to different light exposure and wide variations within individuals is not something that many people are aware of. Post-inflammatory hypopigmentation is a common cause of hypopigmentation. Vitiligo is the most common cause of depigmentation. Vitiligo is an acquired, depigmenting disorder with typical lesions appearing as milky white macules with distinct margins that are not scaly. Hair (including eyebrows and eyelashes) can be dep...
Source: PediatricEducation.org - November 12, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Prematurity Awareness Month
is observed every November, with World Prematurity Day on 17 November, to raise awareness of preterm birth and the concerns of preterm babies and their families worldwide. An estimated 15 million babies around the world are born premature each year and more than one million of them do not survive their early birth.Our review groupsCochrane Neonatal andCochrane Pregnancy and Childbirth prepare and disseminate evidence-based, regularly updated systematic reviews. The scope of Cochrane Neonatal work covers all randomized controlled trials of interventions involving the baby during the first month after birth. Cochrane Pregna...
Source: Cochrane News and Events - November 1, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Medical News Today: What is the difference between methylprednisolone and prednisone?
Methylprednisolone and prednisone are medications that can treat certain health conditions, such as rheumatoid arthritis, by reducing inflammation in the body. Learn about the differences between these corticosteroids here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 31, 2018 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news

FDA Approves Dupilumab for Moderate-to-Severe Asthma FDA Approves Dupilumab for Moderate-to-Severe Asthma
The FDA approved dupilumab as'add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma. 'FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 22, 2018 Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news

FDA Approves Asthma Indication for Dupixent(R) (dupilumab)
Only biologic approved for both moderate and severe asthma patients with eosinophilic phenotype Only biologic approved for oral corticosteroid-dependent asthma, regardless of phenotype Only asthma biologic that offers patient self-administration at h... Biopharmaceuticals, FDA Regeneron Pharmaceuticals, Sanofi, Dupixent, dupilumab, asthma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 22, 2018 Category: Pharmaceuticals Source Type: news

FDA approves asthma indication for Dupixent ® (dupilumab)
The U.S. Food and Drug Administration has approved Dupixent® (dupilumab) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma. (Source: World Pharma News)
Source: World Pharma News - October 22, 2018 Category: Pharmaceuticals Tags: Featured Sanofi Business and Industry Source Type: news

Corticosteroid Use and Intensive Care Unit-Acquired Weakness Corticosteroid Use and Intensive Care Unit-Acquired Weakness
Is there an association between corticosteroid use and ICU-acquired weakness?Critical Care (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 12, 2018 Category: Consumer Health News Tags: Critical Care Journal Article Source Type: news

Bausch Health's BRYHALI(TM) (halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults
In Clinical Trials, BRYHALI Lotion Demonstrated Significant Treatment Success Over Vehicle as Early as Week Two, Which Continued Through Week 12 (Four Weeks Post Treatment)1 New Corticosteroid Lotion Formulation with Safety Proven for Up to Eight Weeks... Biopharmaceuticals, Dermatology, FDA Bausch Health, BRYHALI, halobetasol, Plaque Psoriasis, Psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 8, 2018 Category: Pharmaceuticals Source Type: news

Rituximab Over Tacrolimus in Steroid-Dependent Nephrotic Syndrome? Rituximab Over Tacrolimus in Steroid-Dependent Nephrotic Syndrome?
Dr Desai reviews recent trials comparing steroid-sparing agents used to treat corticosteroid-dependent children with nephrotic syndrome.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 8, 2018 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news

Disruption in combination inhaled corticosteroid therapy may lead to an increased rate of costly exacerbations and hospitalizations for Medicare patients
(American College of Chest Physicians) Disruption of the refill of patients' regular combination inhaled corticosteroid therapy brand may have impacted symptoms and disease control and potentially lead to an increased rate of costly exacerbations and hospitalizations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 4, 2018 Category: International Medicine & Public Health Source Type: news

Implant may improve treatment of diabetic macular oedema
Patients with advanced diabetic macular oedema show improved disease outcomes, including a reduction in central retinal thickness, when treated with a corticosteroid implant, according to research published at the Euretina 2018 meeting.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 1, 2018 Category: Endocrinology Source Type: news

Corticosteroid therapy for sepsis: a clinical practice guideline
This rapid recommendation looks at whether corticosteroids reduce death or improve recovery in people with sepsis or septic shock. The panel make a weak recommendation to give corticosteroids to people with all types and severity of sepsis, based on new evidence. Because they are not certain that they are beneficial, it is also reasonable not to prescribe them. The authors state that patients'values and preferences may guide this decision-making process. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 28, 2018 Category: Consumer Health News Source Type: news

Inhaled Steroids Increase Risk of Nontuberculous Mycobacteria Lung Infections
When using inhaled corticosteroids for the treatment of asthma, COPD, and other airways disease, authors of a new study warn to proceed with caution.   (Source: ConsultantLive)
Source: ConsultantLive - September 28, 2018 Category: Internal Medicine Authors: Mark L. Fuerst Tags: Asthma Source Type: news

Study reveals a promising alternative to corticosteroids in acute renal failure treatment
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) In search of an option for the drug known for causing several side effects, scientists describe the anti-inflammatory properties of protein galectin-1 in tests with rats involving ischemia-reperfusion scenarios. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 20, 2018 Category: International Medicine & Public Health Source Type: news

A natural chemical compound found in natto and cocoa beans found to alleviate airway inflammation
(Natural News) An animal study demonstrated the ability of ligustrazine to alleviate airway inflammation in mice with neutrophilic asthma. Found in cocoa beans and natto, the chemical compound outperformed a corticosteroid drug when it came to alleviating the inflammation caused by this type of asthma. The animal trial was supported by the Shandong University. Its findings were published in the Chinese... (Source: NaturalNews.com)
Source: NaturalNews.com - September 19, 2018 Category: Consumer Health News Source Type: news

What Type of Conservative Treatments Can Help for Plantar Fasciitis?
Discussion The plantar fascia consists of 3 bands of dense connective tissue that originates in the medical calcaneal tubercle and inserts into the base of each of the 5 proximal phalyanxes in a fan-shaped distribution. It acts as a shock absorber and reinforces the medial longitudinal arch as the foot undergoes forward propulsion. The -itis in plantar fasciitis (PF) is a misnomer as it is not an acute inflammation but is a chronic degenerative process involving the plantar fascia aponeurosis of the foot usually at the medial tubercle of the calcaneous. Repetitive strain seems to cause microtearing which then causes a repa...
Source: PediatricEducation.org - September 17, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Inhaled corticosteroids linked to higher infection risk
People using ICS at much greater risk of developing non-TB mycobacteria lung infections Related items fromOnMedica Adjuvanted trivalent flu vaccine best option for over-65s Macrolide antibiotics improve symptoms in bronchiectasis Antibiotics should be restricted for COPD, says NICE Pneumonia guidelines might raise death rate More action needed to treat TB (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 14, 2018 Category: UK Health Source Type: news

Lymphocytic Colitis Responds Rapidly to Budesonide (CME/CE)
(MedPage Today) -- Corticosteroid outperformed mesalamine and placebo in small randomized trial (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - September 13, 2018 Category: Gastroenterology Source Type: news

Corticosteroids at Time of PD-L1 Blockade May Reduce Efficacy in NSCLC
Taking corticosteroids at the time of treatment initiation with PD-L1 inhibitors may lead to inferior outcomes in patients with non –small-cell lung cancer. (Source: CancerNetwork)
Source: CancerNetwork - September 10, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news

Tezepelumab granted Breakthrough Therapy Designation by US FDA
AstraZeneca and its partner Amgen Inc. (Amgen) today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab in patients with severe asthma, without an eosinophilic phenotype, who are receiving inhaled corticosteroids/long-acting beta2-agonists with or without oral corticosteroids and additional asthma controllers. (Source: World Pharma News)
Source: World Pharma News - September 7, 2018 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

Eczema treatment: Apply this type of oil to sore and itchy skin for instant relief
ECZEMA treatments recommended by GPs usually come in the form of moisturisers and topical corticosteroid creams. But some health experts recommend those looking for a natural remedy to sooth their sore and itchy skin with a particular type of oil. (Source: Daily Express - Health)
Source: Daily Express - Health - September 4, 2018 Category: Consumer Health News Source Type: news

FDA Addresses Severe Lack of Pediatric Devices
To address the scarcity of medical devices that are designed specifically for the pediatric population, FDA convened a public meeting and workshop August 13–14, 2018 to delve into the financial, regulatory, and design constraints associated with this challenging endeavor.[1] Speakers at the workshop included FDA regulators, sponsors, clinicians, and members of the American Academy of Pediatrics. The prevailing message from the workshop was that while there are many barriers to the development of pediatric-specific devices, FDA and community in attendance is committed to developing innovative pathways and ...
Source: MDDI - August 30, 2018 Category: Medical Devices Authors: Jessie Huisinga, PhD and Leah Taylor, MS Tags: Regulatory and Compliance Source Type: news

Kala Pharma wins FDA nod for twice-daily ocular corticosteroid
The FDA has approved Kala Pharmaceuticals’ (NASDAQ:KALA) Inveltys to treat post-operative inflammation and pain following ocular surgery. Inveltys is the first twice-daily (BID) ocular corticosteroid approved for this indication, according to the Waltham, Mass. company. While corticosteroids are used following ocular surgery to control inflammation and pain, physicians prescribe ocular steroids to achieve a rapid reduction of inflammation and to promote healing. All other ocular steroids are only approved for four-times-a-day dosing. Get the full story on our sister site, Drug Delivery Business. The po...
Source: Mass Device - August 24, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Clinical Trials Food & Drug Administration (FDA) Optical/Ophthalmic Pain Management Pharma Pharmaceuticals Kala Pharmaceuticals Source Type: news

Arthritis Linked with Preterm Delivery
(MedPage Today) -- Active disease and corticosteroid exposure implicated (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - August 22, 2018 Category: OBGYN Source Type: news

Mount Sinai receives NIH Grant to study use of inhaled corticosteroids for sickle cell treatment
(The Mount Sinai Hospital / Mount Sinai School of Medicine) The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell disease (SCD) in individuals who do not have asthma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 13, 2018 Category: International Medicine & Public Health Source Type: news

Asthma inhalers found to make women fat while increasing risk of heart disease
(Natural News) Corticosteroids in asthma inhalers could make women fat and increase the risk of metabolic syndrome, a recent study found. Corticosteroids are widely-used anti-inflammatory agents that come in many forms — such as inhalers, nasal sprays, tablets, injections and cream — and are prescribed to ease symptoms of asthma and other respiratory diseases. Metabolic... (Source: NaturalNews.com)
Source: NaturalNews.com - August 9, 2018 Category: Consumer Health News Source Type: news

FDA Panel Votes Against Recommending Mepolizumab for COPD FDA Panel Votes Against Recommending Mepolizumab for COPD
An FDA panel recommended against mepolizumab as add-on treatment to inhaled corticosteroid-based maintenance treatment in patients with COPD guided by blood eosinophil counts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 26, 2018 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Rhodococcus equi Pulmonary Infection in an Immunocompromised Patient: Case Report and Literature Review
We present a case of R. equi lung abscess in a 49-year-old immunocompromised male who was on long-term corticosteroid therapy. The patient recovered soon after he was treated with vancomycin and imipenem. The identification of R. equi is often difficult, because it closely resembles other bacterial pathogens, such as diphtheroids and Mycobacterium and Nocardia species. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - July 21, 2018 Category: Microbiology Authors: Zeti Norfidiyati Salmuna, Wan Amani Wan Abdul Azim, Azian Harun Tags: Case Report Source Type: news